Board of Directors
Biography - Anika Alvanzo, MD, MS, FACP, DFASAM
Anika Alvanzo, MD, MS, FACP, DFASAM is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and Addiction Medicine. She has been a member of the American Society of Addiction Medicine (ASAM) since 2008 and is a Distinguished Fellow of ASAM.
Dr. Alvanzo currently serves as Immediate Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM), Chair of the ASAM Annual Conference Program Planning Committee and Region V Director for the ASAM Board of Directors. Dr. Alvanzo is the Eastern Region Medical Director for Pyramid Healthcare, Inc., where her role is to optimize and standardize the medical care, with emphasis on substance withdrawal management and pharmacotherapy, in the residential and outpatient addiction treatment programs in Eastern Pennsylvania and Central Maryland.
Prior to this, Dr. Alvanzo spent twelve years as faculty in the Divisions of General Internal Medicine and Addiction Medicine at Johns Hopkins University School of Medicine where she held a variety of clinical leadership roles, including Associate Medical Director of Addiction Treatment Services and the Center for Addiction and Pregnancy and Medical Director of the Broadway Center for Addiction, comprehensive, outpatient substance use disorder treatment (SUD) programs on the Johns Hopkin Bayview and Johns Hopkins Hospital campuses, respectively. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service providing clinical consultation, brief intervention and treatment linkage services for inpatients with substance use disorders admitted to the Department of Medicine general and subspecialty services. In addition, for seven years, she directed the Addiction Medicine Rotation for the Johns Hopkins Medicine-Pediatrics Urban Health and Urban Health Primary Care Internal Medicine Residency track programs.
Dr. Alvanzo has served as an expert on National Institutes of Health (NIH), Substance Abuse and Mental Health Services Administration (SAMHSA), National Academies of Sciences, Engineering and Medicine (NASEM) panels regarding opioids and integration of recovery-oriented care in various medical settings. Most recently, Dr. Alvanzo served as a member of the National Quality Forum (NQF) Opioid Technical Expert Panel, which contributed to the February 20, 2020 report, “Opioids and Opioid Use Disorder: Quality Measurement Priorities” and was a member of the ASAM Alcohol Withdrawal Management Guidelines Committee.
Her research interests include gender and race/ethnicity differences in the risk for substance use disorders and the association between psychological trauma, posttraumatic stress, and substance use, particularly in women.